Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


Wistron Opens $700M Texas AI Factory to Build Nvidia GB300 Superchips
South Korea’s Coupang Fine Sparks U.S. Criticism, Raising Concerns Over Bilateral Ties
Samsung Eyes Up to $1.14 Billion Investment in AI Startup Mistral
Gold Price Jumps Near 2% Above $4,080 as Middle East Tensions Lift Safe-Haven Demand
SpaceX Q2 Earnings on Aug. 4 Set Stage for Historic Insider Share Unlock
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge
US Dollar Holds Near One-Week High as Middle East Tensions and Oil Prices Drive Market Sentiment
ASEAN Ministers Warn Middle East Conflict Threatens Regional Stability and Energy Security
TSMC Sees Multi-Year AI Chip Demand as Arizona Expansion Reaches $265 Billion
GM Q2 Earnings Beat Estimates as General Motors Raises 2026 Profit Outlook
Gold Climbs Above $4,000 as Middle East Tensions and Fed Outlook Drive Safe-Haven Demand
Bank of America Says These Overlooked AI Stocks Could Be the Next Winners
SpaceX Targets Thursday Launch for Starship's 13th Test Flight After Last-Minute Delay
Tesla Stock Outlook: Strong EV Sales Boost Earnings, but AI Projects Drive Long-Term Value
Chalco Shares Jump as Chinalco Plans Up to $300 Million Stake Increase
US Stock Futures Steady Ahead of Tesla, Alphabet Earnings as Iran Conflict Keeps Markets on Edge 



